Literature DB >> 35976411

Does systemic lupus erythematosus impact the peri-operative complication rates following primary total knee arthroplasty? A national inpatient sample-based large-scale study.

Vibhu Krishnan Viswanathan1, Vishaal Sakthivelnathan2, Tejas Senthil3, Anil Menedal4, Prabhudev Prasad Purudappa5, Varatharaj Mounasamy6, Senthil Sambandam7.   

Abstract

INTRODUCTION: Consequent to improved life expectancies, there has been a substantial increase in the proportion of patients with systemic lupus erythematosus (SLE) undergoing total knee arthroplasty (TKA) over the past 2 decades. In comparison to the other inflammatory disorders, the complication rates and post-operative outcome in patients with SLE are less clearly understood, owing to the paucity of evidence in the literature.
METHODS: Patients who underwent TKA between 2016 and 2019 were identified (ICD-10CMP code) using the National Inpatient Sample (NIS) database and then classified into one of the two groups, namely those with SLE (ICD-10-CM; code710.0) and those without SLE (NSLE). Demographic details, co-morbidities, details regarding hospital stay, costs incurred, and complications encountered of this patient cohort were analysed and compared between the two groups.
RESULTS: Overall, among 5,58,361 patients undergoing TKA, 2,094 (0.38%) patients had SLE. The SLE group was significantly younger than NSLE population (62.2 ± 9.9 vs 66.7 ± 9.5 years; p < 0.001). The proportion of female and African-American patients was higher in the SLE group (p < 0.001). SLE patients had a significantly longer hospital stay (p < 0.001) and greater hospital-related expenditure (p < 0.001). Among the peri-operative complications, SLE patients had significantly greater risk of developing post-operative anemia (19.2% in SLE vs 15.3% in NSLE; p < 0.001), requiring blood transfusion (2.8% in SLE vs 1.5% in NSLE; p < 0.001), and acquiring peri-prosthetic joint infections (1.9% in SLE vs 1% in NSLE; p < 0.001).
CONCLUSION: The presence of SLE significantly lengthens hospital stay, and augments the health-care-related costs in patients undergoing TKA. The rates of peri-prosthetic infections, post-operative anemia, and need for blood transfusions are significantly greater in SLE patients.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Complications; Health care expenditure; Outcome; Systemic lupus erythematosus; Total knee arthroplasty

Year:  2022        PMID: 35976411     DOI: 10.1007/s00402-022-04581-4

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   2.928


  16 in total

1.  Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample.

Authors:  Jasvinder A Singh; Shaohua Yu; Lang Chen; John D Cleveland
Journal:  J Rheumatol       Date:  2019-04-15       Impact factor: 4.666

Review 2.  Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review.

Authors:  Susan M Goodman; Anne R Bass
Journal:  BMC Rheumatol       Date:  2018-01-30

3.  Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis.

Authors:  Bheeshma Ravi; Ruth Croxford; Simon Hollands; J Michael Paterson; Earl Bogoch; Hans Kreder; Gillian A Hawker
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

4.  2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

Authors:  Susan M Goodman; Bryan Springer; Gordon Guyatt; Matthew P Abdel; Vinod Dasa; Michael George; Ora Gewurz-Singer; Jon T Giles; Beverly Johnson; Steve Lee; Lisa A Mandl; Michael A Mont; Peter Sculco; Scott Sporer; Louis Stryker; Marat Turgunbaev; Barry Brause; Antonia F Chen; Jeremy Gililland; Mark Goodman; Arlene Hurley-Rosenblatt; Kyriakos Kirou; Elena Losina; Ronald MacKenzie; Kaleb Michaud; Ted Mikuls; Linda Russell; Alexander Sah; Amy S Miller; Jasvinder A Singh; Adolph Yates
Journal:  J Arthroplasty       Date:  2017-06-16       Impact factor: 4.757

5.  Stable occurrence of knee and hip total joint replacement in Central Finland between 1986 and 2003: an indication of improved long-term outcomes of rheumatoid arthritis.

Authors:  Tuulikki Sokka; Hannu Kautiainen; Pekka Hannonen
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

6.  Patients with Systemic Lupus Erythematosus Have Increased Risk of Short-term Adverse Events after Total Hip Arthroplasty.

Authors:  Jordan E Roberts; Lisa A Mandl; Edwin P Su; David J Mayman; Mark P Figgie; Arielle W Fein; Yuo-Yu Lee; Ummara Shah; Susan M Goodman
Journal:  J Rheumatol       Date:  2016-06-15       Impact factor: 4.666

7.  Patients with rheumatoid arthritis are more likely to have pain and poor function after total hip replacements than patients with osteoarthritis.

Authors:  Susan M Goodman; Danielle N Ramsden-Stein; Wei-Ti Huang; Rebecca Zhu; Mark P Figgie; Michael M Alexiades; Lisa A Mandl
Journal:  J Rheumatol       Date:  2014-08-01       Impact factor: 4.666

Review 8.  Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.

Authors:  Vibeke Strand; Jasvinder A Singh
Journal:  Am J Manag Care       Date:  2008-04       Impact factor: 2.229

9.  US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis.

Authors:  Christina Mertelsmann-Voss; Stephen Lyman; Ting Jung Pan; Susan M Goodman; Mark P Figgie; Lisa A Mandl
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

10.  Revision total knee arthroplasty (TKA): mid-term outcomes and bone loss/quality evaluation and treatment.

Authors:  Federica Rosso; Umberto Cottino; Federico Dettoni; Matteo Bruzzone; Davide Edoardo Bonasia; Roberto Rossi
Journal:  J Orthop Surg Res       Date:  2019-08-28       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.